SANDOZ CANADA INC. C/O UPS SCS — Tacrolimus Importer Profile
Pharmaceutical Importer · #10 buyer for Tacrolimus · $1.6M import value · 37 shipments · CANADA · DGFT Verified
SANDOZ CANADA INC. C/O UPS SCS is the #10 importer of Tacrolimus from India with $1.6M in import value and 37 verified shipments. SANDOZ CANADA INC. C/O UPS SCS holds a 0.8% market share in Tacrolimus imports based in CANADA. The company sources from 1 verified supplier across 20 formulations shipped to 1 country. Overall, SANDOZ CANADA INC. C/O UPS SCS imports 3 pharmaceutical products worth $5.5M across 3 therapeutic categories.
SANDOZ CANADA INC. C/O UPS SCS — Tacrolimus Import Profile: Suppliers, Formulations & Sources

Who Actually Supplies Tacrolimus to SANDOZ CANADA INC. C/O UPS SCS?
Verified from 37 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SANDOZ PRIVATE LIMITED | $1.6M | 37 | 100.0% |
SANDOZ CANADA INC. C/O UPS SCS sources Tacrolimus from 1 verified Indian supplier based on 37 customs records. The primary supplier is SANDOZ PRIVATE LIMITED accounting for 100.0% of imports.
How Does SANDOZ CANADA INC. C/O UPS SCS Compare to Nearest Tacrolimus Importers?
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | ASCEND LABORATORIES LLC | UNITED STATES | $2.1M | 43 | $50.0K |
| 12 | SANDOZ PTY LTD | AUSTRALIA | $1.9M | 37 | $50.0K |
| 10 | SANDOZ CANADA INC. C/O UPS SCS ★ | CANADA | $1.6M | 33 | $50.0K |
| 14 | DR REDDYS LABORATORIES INC | UNITED STATES | $1.4M | 28 | $50.0K |
| 17 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $1.4M | 28 | $50.0K |
SANDOZ CANADA INC. C/O UPS SCS ranks #10 among 727 Tacrolimus importers from India. Average shipment value of $50.0K compared to the market average of $70.2K. The closest competitors by value are ASCEND LABORATORIES LLC and SANDOZ PTY LTD.
Where Does SANDOZ CANADA INC. C/O UPS SCS Import Tacrolimus To?
Destination countries from 37 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.6M | 37 | 100.0% |
SANDOZ CANADA INC. C/O UPS SCS imports Tacrolimus to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $1.6M.
What Tacrolimus Formulations Does SANDOZ CANADA INC. C/O UPS SCS Import?
| Formulation | Value | Shipments |
|---|---|---|
| TACROLIMUS SDZ 1MG 100HGC BO CA MATERIAL | $250.0K | 5 |
| TACROLIMUS SDZ 1MG 100HGC BO CA MATERIALNO. - 44045829 | $250.0K | 5 |
| Material No. - 44045830 TACROLIMUS SDZ 5 | $150.0K | 3 |
| Material No. - 44045829 TACROLIMUS SDZ 1 | $100.0K | 2 |
| MATERIAL NO. 44045829 TACROLIMUS SDZ 1MG 100HGC BO CA | $100.0K | 2 |
| TACROLIMUS SDZ 1MG 100HGC BO CA , MATERIAL NO : 44045829 | $100.0K | 2 |
| TACROLIMUS SDZ 1MG 100HGC BO CA MATERIALNO. - 44045829PCS | $79.6K | 2 |
| TACROLIMUS SDZ HGC 0.5MG 100HGC BO CA MATERIAL NO. - 44045828PCS | $67.0K | 2 |
| TACROLIMUS SDZ 5MG 100HGC BO CA MATERIAL | $50.0K | 1 |
| TACROLIMUS SDZ 5MG 100HGC BO CA, MATERIAL NO. - 44045830 | $50.0K | 1 |
SANDOZ CANADA INC. C/O UPS SCS imports 20 distinct Tacrolimus formulations from India. The top formulation is TACROLIMUS SDZ 1MG 100HGC BO CA MATERIAL with 5 shipments worth $250.0K.
Regulatory Requirements: Importing Tacrolimus into Canada
What SANDOZ CANADA INC. C/O UPS SCS and other importers must comply with to import Tacrolimus from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Tacrolimus
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Tacrolimus from India and How Much Does SANDOZ CANADA INC. C/O UPS SCS Import?
India exported $51.0M worth of Tacrolimus through 4,611 shipments from 299 suppliers to 127 countries, serving 727 buyers globally. SANDOZ CANADA INC. C/O UPS SCS imports $1.6M of this total, accounting for 0.8% of India's Tacrolimus exports with 37 shipments from CANADA. This is verified from 37 customs shipment records covering 20 distinct formulations.
What Is the Average Order Value for SANDOZ CANADA INC. C/O UPS SCS's Tacrolimus Imports?
SANDOZ CANADA INC. C/O UPS SCS's average Tacrolimus order value is $44.4K per consignment, based on 37 shipments totaling $1.6M. SANDOZ CANADA INC. C/O UPS SCS is based in CANADA and ranks #10 among all Tacrolimus importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Tacrolimus to SANDOZ CANADA INC. C/O UPS SCS?
SANDOZ CANADA INC. C/O UPS SCS sources Tacrolimus from 1 verified Indian supplier: SANDOZ PRIVATE LIMITED ($1.6M, 100.0%). This is based on 37 customs records.
How Does SANDOZ CANADA INC. C/O UPS SCS Compare to Other Tacrolimus Importers?
SANDOZ CANADA INC. C/O UPS SCS ranks #10 among 727 Tacrolimus importers from India with a 0.8% market share. The top 3 importers are LEK D.D ($9.8M), SANDOZ INC. C/O EXEL, INC. ($9.6M), EVERSANA LIFE SCIENCES SERVICES,LLC ($7.1M). SANDOZ CANADA INC. C/O UPS SCS processed 37 shipments from CANADA.
About SANDOZ CANADA INC. C/O UPS SCS
SANDOZ CANADA INC. C/O UPS SCS imports 3 products worth $5.5M. Beyond Tacrolimus, top products include Sitagliptin, Dapagliflozin. View the complete SANDOZ CANADA INC. C/O UPS SCS profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Tacrolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Tacrolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SANDOZ CANADA INC. C/O UPS SCS matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SANDOZ CANADA INC. C/O UPS SCS's capped import value divided by total capped export value for Tacrolimus across all Indian exporters.
- 5.Verified Records: This page is backed by 37 individual customs records matching SANDOZ CANADA INC. C/O UPS SCS importing Tacrolimus, covering 20 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 127+ countries, 727+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Tacrolimus Import Data for SANDOZ CANADA INC. C/O UPS SCS
Access order-level details, pricing data, supplier connections, and competitive analysis for SANDOZ CANADA INC. C/O UPS SCS's Tacrolimus imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SANDOZ CANADA INC. C/O UPS SCS
Full Company Profile →
3 products · $5.5M total trade · 3 categories
SANDOZ CANADA INC. C/O UPS SCS × Tacrolimus
Verified from customs records
Company Overview
Top Products by SANDOZ CANADA INC. C/O UPS SCS
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SANDOZ CANADA INC. C/O UPS SCS.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tacrolimus. For current order-level data, contact TransData Nexus.